Somatostatin suppresses endothelin-1-induced rat hepatic stellate cell contraction via somatostatin receptor subtype 1.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Gastroenterology

• Publication date

  2001-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1053/GAST.2001.27971PMID 11606505
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Octreotide potentiates PKC-dependent vasoconstrictors in portal-hypertensive and control rats.

  2001cited by this paper
• Octreotide and its effects on portal circulation.

  2001cited by this paper
• Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension.

  2001cited by this paper
• Wound‐induced migration of rat hepatic stellate cells is modulated by endothelin‐1 through rho‐kinase‐mediated alterations in the acto‐myosin cytoskeleton

  2001cited by this paper
• Formation of normal desmin intermediate filaments in mouse hepatic stellate cells requires vimentin

  2001cited by this paper
• Immunocytochemical study on the liver innervation in patients with cirrhosis.

  2000cited by this paper
• Local arterial vasoconstriction induced by octreotide in patients with cirrhosis

  2000cited by this paper
• Identification and characterization of subtype selective somatostatin receptor agonists

  2000cited by this paper
• Somatostatin receptor subtype expression and function in human vascular tissue.

  2000cited by this paper
• Transjugular Intrahepatic Portosystemic Shunt

  1999cited by this paper
• Class VI intermediate filament protein nestin is induced during activation of rat hepatic stellate cells

  1999cited by this paper
• Differential regulation of somatostatin receptor types 1–5 in rat aorta after angioplasty

  1999cited by this paper
• Pharmacological Treatment of Portal Hypertension: An Evidence-Based Approach

  1999cited by this paper
• Somatostatin and its receptor family.

  1999cited by this paper
• Somatostatin or Octreotide in Acute Variceal Bleeding

  1999cited by this paper
• ROCK inhibitor Y-27632 attenuates stellate cell contraction and portal pressure increase induced by endothelin-1.

  1999cited by this paper
• Endoscopic Treatments for Portal Hypertension

  1999cited by this paper
• Gene Expression of Endothelin-1 and ETA and ETB Receptors in Human Cirrhosis: Relationship with Hepatic Hemodynamics

  1998cited by this paper
• Cellular localization of endothelin‐1 and increased production in liver injury in the rat: Potential for autocrine and paracrine effects on stellate cells

  1998cited by this paper
• A somatostatin receptor 1 selective ligand inhibits Ca2+ currents in rat insulinoma 1046‐38 cells

  1998cited by this paper
• Purification of rat hepatic stellate cells by side scatter–activated cell sorting

  1998cited by this paper
• Beneficial hemodynamic effects of bosentan, a mixed ETA and ETB receptor antagonist, in portal hypertensive rats

  1998cited by this paper
• Activation of rat hepatic stellate cells in culture is associated with increased sensitivity to endothelin 1

  1998cited by this paper
• Pharmacological treatment of portal hypertension: present and future.

  1998cited by this paper
• Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry.

  1998cited by this paper
• The hepatic circulation in health and disease: Report of a single‐topic symposium

  1998cited by this paper
• Intrahepatic Modulation of Portal Pressure and Its Role in Portal Hypertension

  1998cited by this paper
• Distribution of somatostatin receptor messenger RNAs in the rat gastrointestinal tract.

  1997cited by this paper
• Vascular actions of octreotide in the portal hypertensive rat

  1997cited by this paper
• Molecular pharmacology of somatostatin receptor subtypes

  1997cited by this paper
• Expression of the five somatostatin receptor (SSTR1-5) subtypes in rat pituitary somatotrophes: quantitative analysis by double-layer immunofluorescence confocal microscopy.

  1997cited by this paper
• The cellular pathogenesis of portal hypertension: Stellate cell contractility, endothelin, and nitric oxide

  1997cited by this paper
• Daily profile of plasma endothelin-1 and -3 in pre-ascitic cirrhosis: relationships with the arterial pressure and renal function.

  1997cited by this paper
• Coupling of rat somatostatin receptor subtypes to a G‐protein gated inwardly rectifying potassium channel (GIRK1)

  1997cited by this paper
• Expression of the Five Somatostatin Receptor (SSTR1-5) Subtypes in Rat Pituitary Somatotrophes: Quantitative Analysis by Double-Label Immunofluorescence Confocal Microscopy.

  1997cited by this paper
• Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance

  1996cited by this paper
• Phosphorylation and Activation of Myosin by Rho-associated Kinase (Rho-kinase)*

  1996cited by this paper
• Morphological study of endothelin-1-induced contraction of cultured hepatic stellate cells on hydrated collagen gels

  1996cited by this paper
• Somatostatin reduces gastric mucosal blood flow in patients with portal hypertensive gastropathy

  1996cited by this paper
• Agonist-dependent regulation of cloned human somatostatin receptor types 1-5 (hSSTR1-5): subtype selective internalization or upregulation.

  1996cited by this paper
• Enzymatic release of oligosaccharides from glycoproteins for chromatographic and electrophoretic analysis.

  1996cited by this paper
• Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells.

  1996cited by this paper
• Rho-stimulated contractility drives the formation of stress fibers and focal adhesions

  1996cited by this paper
• Regulation of Myosin Phosphatase by Rho and Rho-Associated Kinase (Rho-Kinase)

  1996cited by this paper
• Somatostatin‐Induced Contraction of Human Isolated Saphenous Vein Involves sst2 Receptor‐Mediated Activation of L‐Type Calcium Channels

  1995cited by this paper
• Action of endothelins on hepatic stellate cells

  1995cited by this paper
• Effects of somatostatin on cultured human mesangial cells.

  1995cited by this paper
• Hepatic stellate (ITO) cells: expanding roles for a liver-specific pericyte.

  1995cited by this paper
• Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: A double‐blind hemodynamic investigation

  1995cited by this paper
• Vasoactive effect of endothelin‐1 on rat liver in vivo

  1994cited by this paper
• Somatostatin receptor subtype SSTR2 mediates the inhibition of high‐voltage‐activated calcium channels by somatostatin and its analogue SMS 201‐995

  1994cited by this paper
• Somatostatin-induced inhibition of neuronal Ca2+ current modulated by cGMP-dependent protein kinase

  1994cited by this paper
• Endothelin-1 induces direct constriction of hepatic sinusoids.

  1994cited by this paper
• The effect of different doses of a bolus injection of somatostatin combined with a slow infusion on transmural oesophageal variceal pressure in patients with cirrhosis.

  1994cited by this paper
• Octreotide prevents postprandial splanchnic hyperemia in patients with portal hypertension.

  1994cited by this paper
• Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo.

  1993cited by this paper
• Tissue distribution of somatostatin receptor subtype messenger ribonucleic acid in the rat.

  1993cited by this paper
• The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus.

  1993cited by this paper
• Identification of connective tissue gene transcripts in freshly isolated parenchymal, endothelial, Kupffer and fat-storing cells by northern hybridization analysis.

  1993cited by this paper
• Endothelin receptors in rat liver: lipocytes as a contractile target for endothelin 1.

  1993cited by this paper
• Regulation of endothelin‐1 action on the perfused rat liver

  1993cited by this paper
• Expression cloning of a rat brain somatostatin receptor cDNA.

  1992cited by this paper
• The role of portosystemic shunting in the management of portal hypertension.

  1992cited by this paper
• Effect of somatostatin on mesenteric vascular resistance in normal and portal hypertensive rats.

  1992cited by this paper
• Cloning and expression of a rat somatostatin receptor enriched in brain.

  1992cited by this paper
• Molecular cloning of a somatostatin-28 receptor and comparison of its expression pattern with that of a somatostatin-14 receptor in rat brain.

  1992cited by this paper
• Glucagon hinders the effects of somatostatin on portal hypertension. A study in rats with partial portal vein ligation.

  1991cited by this paper
• Endothelins produced by endothelial cells promote collagen gel contraction by fibroblasts

  1991cited by this paper
• Cloning of a cDNA Encoding a Novel Putative G-Protein–Coupled Receptor Expressed in Specific Rat Brain Regions

  1991cited by this paper
• Endothelin, a potent peptide agonist in the liver.

  1990cited by this paper
• Effects of somatostatin on splanchnic hemodynamics and plasma glucagon in portal hypertensive rats.

  1988cited by this paper
• Selective suppression of insulin-induced proliferation of cultured human hepatoma cells by somatostatin.

  1987cited by this paper
• Insulin resistance and delayed clearance of peptide hormones in cirrhotic rat liver.

  1987cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Microvascular pericyte contractility in vitro: comparison with other cells of the vascular wall

  1987cited by this paper
• Effect of somatostatin on oesophageal variceal pressure assessed by direct measurement.

  1986cited by this paper
• Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: Comparison with vasopressin

  1981cited by this paper
• Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.

  1981cited by this paper
• Metabolic clearance and plasma half-disappearance time of exogenous somatostatin in man.

  1979cited by this paper
• DNA sequencing with chain-terminating inhibitors.

  1977cited by this paper
• Influence of somatostatin on splanchnic glucose metabolism in postabsorptive and 60-hour fasted humans.

  1977cited by this paper

• Investigation of phytochemical profile and in vivo anti-proliferative effect of Laetiporus versisporus (Lloyd) Imazeki mushroom against diethylnitrosamine-induced hepatocellular carcinoma

  2021cites this paper
• Therapeutic Potential of

  2021cites this paper
• Cortistatin regulates fibrosis and myofibroblast activation in experimental hepatotoxic‐ and cholestatic‐induced liver injury

  2021influential citation
• Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic Treatment of Non-Alcoholic Fatty Liver Disease

  2021cites this paper
• Therapeutic Potential of Cucumis melo (L.) Fruit Extract and Its Silver Nanopartciles Against DEN-Induced Hepatocellular Cancer in Rats

  2021cites this paper
• Somatostatin and the “Small-For-Size” Liver

  2019cites this paper
• Somatostatin as Inflow Modulator in Liver-transplant Recipients With Severe Portal Hypertension: A Randomized Trial.

  2019cites this paper
• Ciblage pharmacologique du microenvironnement de l'adénocarcinome canalaire pancréatique

  2018cites this paper
• Neuroanatomical connections between kisspeptin neurones and somatostatin neurones in the female and male rat hypothalamus: A possible involvement of SSTR1 in kisspeptin release

  2018cites this paper
• Cyclooxygenase-2 up-regulates hepatic somatostatin receptor 2 expression

  2018cites this paper
• Octreotide modulates the expression of somatostatin receptor subtypes in inflamed rat jejunum induced by Cryptosporidium parvum

  2018cites this paper
• Somatostatin in hepatocellular carcinoma: experimental and therapeutic implications

  2018cites this paper
• Gene expression profiling reveals a possible role for somatostatin in the innate immune response of the liver

  2015cites this paper
• Sodium Ferulate Reduces Portal Pressure Through Inhibition of RhoA/Rho-Kinase and Activation of Endothelial Nitric Oxide Synthase in Cirrhotic Rats

  2015cites this paper
• Lanreotide and its Potential Applications in Polycystic Kidney and Liver Diseases.

  2015cites this paper
• Somatostatin Therapy Protects Porcine Livers in Small‐for‐Size Liver Transplantation

  2014cites this paper
• Octreotide modulates the effects on fibrosis of TNF-α, TGF-β and PDGF in activated rat hepatic stellate cells.

  2014cites this paper
• Hepatic endothelin‐1 and endocannabinoids‐dependent effects of hyperleptinemia in nonalcoholic steatohepatitis‐cirrhotic rats

  2012cites this paper
• Role of resident liver cells in the pathogenesis of schistosomiasis.

  2012cites this paper
• Relaxant effect of prostaglandin D(2)--receptor DP agonist on liver myofibroblast contraction.

  2011cites this paper
• Chemoprevention of hepatocellular carcinoma. Proof of concept in animal models.

  2011cites this paper
• Pathophysiology of portal hypertension and its clinical links.

  2011cites this paper
• Stellate Cells and the Microcirculation

  2011cites this paper
• Blebbistatin inhibits contraction and accelerates migration in mouse hepatic stellate cells

  2010cites this paper
• Downregulation of endothelin-1 by somatostatin improves liver function of recipients undergoing adult-to-adult living donor liver transplantation.

  2010cites this paper
• Postgraduate Course: Integrating Basic Science into Clinical Practice

  2010cites this paper
• Efficacy of lanreotide in preventing the occurrence of chemically induced hepatocellular carcinoma in rats.

  2010cites this paper
• Portal Hypertension and Gastrointestinal Bleeding

  2010cites this paper
• Octreotide decreases portal pressure: Hepatic stellate cells may play a pivotal role

  2010influential citation
• Prostaglandin E2 induces contraction of liver myofibroblasts by activating EP3 and FP prostanoid receptors

  2009cites this paper
• Somatostatin inhibits colon cancer cell growth through cyclooxygenase‐2 downregulation

  2008cites this paper
• Stellate cell contraction: role, regulation, and potential therapeutic target.

  2008cites this paper
• Regulation of Sinusoidal Perfusion in Portal Hypertension

  2008cites this paper
• Inhibition of early preneoplastic events in the rat liver by the somatostatin analog lanreotide

  2007cites this paper
• Influence of somatostatin and octreotide on liver microcirculation in an experimental mouse model of cirrhosis studied by intravital fluorescence microscopy

  2007cites this paper
• Clinical trial: the effect of somatostatin vs. octreotide in preventing post‐endoscopic increase in hepatic venous pressure gradient in cirrhotics with bleeding varices

  2007cites this paper
• Expression of somatostatin receptors in splanchnic blood vessels of normal and cirrhotic rats

  2007cites this paper
• A potential role of somatostatin and its receptor SSTR4 in the migration of hepatic oval cells

  2006cites this paper
• Attenuation of acute phase shear stress by somatostatin improves small‐for‐size liver graft survival

  2006cites this paper
• carcinomahuman liver and in hepatocellular Expression of somatostatin receptors in normal and

  2006cites this paper
• Effect of octreotide on contraction of rat hepatic stellate cell

  2006cites this paper
• Somatostatin inhibits pro‐inflammatory cytokine secretion from rat hepatic stellate cells

  2005cites this paper
• Portal hypertension: from pathophysiology to clinical practice

  2005cites this paper
• [Expression of subtypes of somatostatin receptors in rat hepatic stellate cells].

  2005cites this paper
• Somatostatin at nanomolar concentration reduces collagen I and III synthesis by, but not proliferation of activated rat hepatic stellate cells

  2005cites this paper
• Neural connections between the hypothalamus and the liver.

  2004cites this paper
• Suppressive effects of 17beta-estradiol on hepatic fibrosis in CCl4-induced rat model.

  2004cites this paper
• Specific changes of somatostatin mRNA expression in the frontal cortex and hippocampus of diabetic rats

  2004cites this paper
• Expression of somatostatin receptors in normal and cirrhotic human liver and in hepatocellular carcinoma

  2004cites this paper
• Relationship between somatostatin receptors and activation of hepatic stellate cells.

  2004cites this paper
• Management of portal hypertension

  2004cites this paper
• Suppressive effects of 17 b -estradiol on hepatic fibrosis in CCl 4 -induced rat model

  2004cites this paper
• Hemodynamic Effects of Acute and Chronic Administration of Vapreotide in Rats with Cirrhosis

  2004cites this paper
• Antiproliferative and proapoptotic effects of somatostatin on activated hepatic stellate cells.

  2004cites this paper
• Expression of subtypes of somatostatin receptors in hepatic stellate cells.

  2004cites this paper
• Biological activity of somatostatin receptors in GC rat tumour somatotrophs: evidence with sst1-sst5 receptor-selective nonpeptidyl agonists.

  2003cites this paper
• Pharmacological rationale for the use of somatostatin and analogues in portal hypertension

  2003cites this paper
• Graft Injury in Relation to Graft Size in Right Lobe Live Donor Liver Transplantation: A Study of Hepatic Sinusoidal Injury in Correlation With Portal Hemodynamics and Intragraft Gene Expression

  2003cites this paper
• Vascular mediators in the injured liver

  2003cites this paper
• Regulation of endothelin‐A receptor sensitivity by cyclic adenosine monophosphate in rat hepatic stellate cells

  2002cites this paper
• Effects of somatostatin on activated rat hepatic stellate cells and its mechanisms

  2002cites this paper
• Inhibitory effects of somatostatin on tumor necrosis factor-alpha-induced interleukin-6 secretion in human pancreatic periacinar myofibroblasts.

  2002cites this paper
• Does the neuropeptide somatostatin have therapeutic potential against schistosomiasis?

  2002cites this paper
• Somatostatin and analogues in portal hypertension

  2002cites this paper
• Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension

  2002cites this paper
• Actin filament formation, reorganization and migration are impaired in hepatic stellate cells under influence of trichostatin A, a histone deacetylase inhibitor.

  2002cites this paper
• IN MECHANISMS OF DISEASE Vascular Mediators in the Injured Liver

  2002cites this paper
• Elevated Arterial Compliance in Patients with Cirrhosis Is Not Related to Arterial Endothelin-1

  2002influential citation
• Drug treatment for portal hypertension.

  2002cites this paper
• PERSPECTIVES IN CLINICAL HEPATOLOGY Somatostatin and Analogues in Portal Hypertension

  2002cites this paper
• Effect of HMG-CoA reductase inhibitors on proliferation and protein synthesis by rat hepatic stellate cells.

  2001cites this paper